Tech Company Financing Transactions
ChomiX Biotech Funding Round
ChomiX Biotech, based in Nanjing, Jiangsu, secured investment capital from Morning Spring Venture, TigerYeah Capital and Tsinghua Innovation Ventures.
Transaction Overview
Company Name
Announced On
5/15/2023
Transaction Type
Amount
Unknown
Round
Series A
Proceeds Purpose
The company intends to use the funds to further develop its chemoproteomics platforms, expand covalent compound libraries, and initiate several screening projects against traditionally undruggable targets.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Floor 6, Building 08, Accelerator Phase II No. 11 Yaogu Aven
Nanjing, Jiangsu, Undisclosed
CN
Nanjing, Jiangsu, Undisclosed
CN
Phone
Undisclosed
Website
Email Address
Overview
ChomiX Biotech Co., Ltd. is a leading biotechnology company focusing on the preclinical development of innovative small molecule drugs. With chemoproteomics as the core technology, ChomiX is engaged in the discovery of novel lead compounds and protein targets in living cells. Officially operated in 2021, ChomiX has established multiple intersecting platforms, including chemical biology, bioinformatics, medicinal chemistry, molecular and cell biology, etc. Now ChomiX has been authorized numbers of chemoproteomics related patents and built a laboratory with a variety of advanced instruments. ChomiX has partnered with many innovative small molecule drug R&D companies, including PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725), and hundreds of research institutes. ChomiX is committed to quickly breaking through the barriers of undruggable targets and accelerating the discovery of innovative small molecule drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Nan Chen
Browse more venture capital transactions:
Prev: 5/15/2023: M-Kopa venture capital transaction
Next: 5/15/2023: Dualyx venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs